Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN AstraZeneca Quality of Care Evaluations in Advanced Ovarian Cancer Funding Opportunity: Submit LOIs by July 22, 2019
NCCN and Pfizer Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care Funding Opportunity:  Submit Proposals by August 28, 2019
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Research Boards and Committees

Scientific Advisory Boards (SAB): Highly distinguished scientific advisors in oncology representing the country’s top academic institutions serve as advisors on drug-specific scientific advisory boards for Drug Pipeline Review. The NCCN ORP works with industry collaborators to identify and enlist key thought leaders to serve on these boards from NCCN Member Institutions.

RFP Development Teams (RFPDTs):These are committees of expert leaders from NCCN Member Institutions who guide the development of Requests for Proposals (RFPs). The committees focus on formulating projects around the research priorities established through discussions with industry collaborators. Team members specialize in the scientific or clinical research areas of interest to oversee the development of RFPs which elicit proposals that yield studies of high scientific and clinical value. Grantor representative(s) serve as members of the teams in an advisory capacity.

Protocol Development Teams (PDT): Experts with expertise in specific scientific and clinical areas form teams to work with industry collaborators to design protocols and identify Study Chairs or Principal Investigator(s) to conduct studies. Industry collaborators participate in meetings and, depending on whether a study is to be conducted as an investigator initiated trial or as an industry sponsored trial, may serve in either an advisory or a decision-making role.

Scientific Review Committees (SRC): The NCCN ORP establishes qualified Scientific Review Committees (SRCs) to conduct the peer review of research proposals received in response to RFPs. SRC members are from NCCN Member Institutions and have expertise in the specific therapeutic areas relevant to the research project. The NCCN ORP SRC review process meets the general NIH standards of peer review and funding by meeting the following three criteria:

  1. the peer review system uses external reviewers and is free of conflict-of-interest
  2. the ranking or rating system in the review process is based on the scientific merit of the proposed research
  3. the funding system is based primarily on the peer review ranking or rating of the research application.

The NCCN ORP requires major reviews by two (2) members of the SRC with discussion and ranking of proposals by all members of the SRC. Grantor representatives serve in an advisory capacity to these committees and are given the opportunity to review each of the proposals prior to the formal review. Grantors may request elimination of particular proposals from scientific review if they duplicate already well-studied concepts or raise safety concerns.